- Home
- NLSP vs LTRY Comparison
NLSP vs LTRY Comparison
Compare NLSP & LTRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- LTRY
- Stock Information
- Founded
- NLSP 2015
- LTRY 2015
- Country
- NLSP Switzerland
- LTRY United States
- Employees
- NLSP N/A
- LTRY N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- LTRY Computer Software: Prepackaged Software
- Sector
- NLSP Health Care
- LTRY Technology
- Exchange
- NLSP Nasdaq
- LTRY Nasdaq
- Market Cap
- NLSP 12.4M
- LTRY N/A
- IPO Year
- NLSP 2021
- LTRY N/A
- Fundamental
- Price
- NLSP $2.86
- LTRY $1.26
- Analyst Decision
- NLSP
- LTRY
- Analyst Count
- NLSP 0
- LTRY 0
- Target Price
- NLSP N/A
- LTRY N/A
- AVG Volume (30 Days)
- NLSP 385.9K
- LTRY 1.4M
- Earning Date
- NLSP 07-07-2025
- LTRY 08-18-2025
- Dividend Yield
- NLSP N/A
- LTRY N/A
- EPS Growth
- NLSP N/A
- LTRY N/A
- EPS
- NLSP N/A
- LTRY N/A
- Revenue
- NLSP N/A
- LTRY $1,030,318.00
- Revenue This Year
- NLSP N/A
- LTRY N/A
- Revenue Next Year
- NLSP N/A
- LTRY N/A
- P/E Ratio
- NLSP N/A
- LTRY N/A
- Revenue Growth
- NLSP N/A
- LTRY N/A
- 52 Week Low
- NLSP $1.30
- LTRY $0.22
- 52 Week High
- NLSP $15.59
- LTRY $2.65
- Technical
- Relative Strength Index (RSI)
- NLSP 68.80
- LTRY 49.99
- Support Level
- NLSP $2.51
- LTRY $1.09
- Resistance Level
- NLSP $3.08
- LTRY $1.39
- Average True Range (ATR)
- NLSP 0.21
- LTRY 0.10
- MACD
- NLSP 0.04
- LTRY -0.02
- Stochastic Oscillator
- NLSP 75.17
- LTRY 51.43
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.